Search bioRxiv⌕ Search

Biology subjects

Mulder, I. A.

Publications and source records attributed to Mulder, I. A..

2 recordsLinked to original sources

Loss of contractile pericytes and their impaired calcium dynamics exacerbate brain ischemic stroke of awake mice in acute and chronic phases

Ischemic stroke disrupts neurovascular uncoupling, in which neuronal activity fails to evoke appropriate microvascular blood flow responses, despite successful recanalization of upstream arteries. The cellular mechanisms underlying this dysfunction remain poorly defined. We examined Ca{superscript 2} signaling and contractile dynamics of vascular smooth muscle cells, precapillary sphincters and contractile pericytes, using two-photon microscopy and laser speckle imaging in awake mice subjected to transient middle cerebral artery occlusion. During occlusion, precapillary sphincters exhibited pronounced Ca{superscript 2} elevations and constriction, amplifying downstream capillary resistance. Following reperfusion, elevated Ca{superscript 2} signals persisted without proportional diameter changes, indicating early uncoupling between Ca{superscript 2} dynamics and vascular responses. In the chronic phase, loss of precapillary sphincters-associated contractile pericytes was associated with capillary dilation and persistent neurovascular uncoupling. Although partial recovery of pericyte coverage and Ca{superscript 2} activity occurred, stimulus-evoked vascular responses remained blunted. These findings highlight precapillary sphincters as a key contributor to ischemia-induced microvascular dysfunction.

neuroscience↗

Temporal Dynamics of Complement Activation and Outcome in Patients with Acute Ischemic Stroke

Immune-mediated inflammatory responses exacerbate brain injury and affect the prognosis in acute ischemic stroke (AIS). We characterized longitudinal complement activation after AIS using serial plasma samples from 10 patients and 8 controls. Initial markers of classical (C1q), lectin (mannose-binding lectin [MBL]), and alternative (Factor Bb [CFBb]) pathways, as well as regulatory (Factor H [CFH]) and downstream markers (C3a, C5a and C5b-9) were measured by ELISA at 9 time points. Stroke patients showed broad complement activation with increased C1q, MBL, CFBb, C3a, C5a, and C5b-9, and reduced CFH. C1q, MBL, and CFBb peaked around day 17. MBL was higher in patients with poor outcome, CFBb was higher with good outcome, and C5b-9 in severe strokes. These findings reveal pathway-specific complement dynamics after AIS and support complement as a target for stage-specific therapy.

neuroscience↗